Merck is set to announce its second-quarter results later this month, and analysts anticipate double-digit earnings dip.

Merck is set to announce its second-quarter results later this month, and analysts anticipate double-digit earnings dip.

Merck is a massive company with strong fundamentals and underlying value at a heavily discounted price. Click here to find ...

Verona Pharma, a year after receiving regulatory approval for its landmark chronic obstructive pulmonary disease (COPD) treatment, is being acquired by pharmaceutical giant Merck in a deal worth about ...

In a report released yesterday, Courtney Breen from Bernstein maintained a Hold rating on Merck & Company. The company’s shares closed yesterday at $81.37. Don’t Miss TipRanks ...

U.S. pharmaceutical firm Merck will purchase U.K.-based Verona Pharma for around $10 billion, the companies said Wednesday.

Stocks are slightly higher on Wall Street as the Trump administration seeks to win more deals with global trading partners.

Merck MRK is expected to face several hurdles over the next few years that could affect its long-term growth trajectory, ...